Phenomic AI
Toronto, CA · 8 known investors
Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
SC
Sam CooperCo-founder & CTO
OK
Oren KrausCo-founder
Investors · 8
Cantos Ventures✓ verifiedSan Francisco · $400K – $1.5M
AV8 VenturesPalo Alto · $500K – $10M
CTI Life Sciences Fund L.P.Montréal
Garage Capital
Hemi Ventures, LlcPalo Alto · $250K – $500Kvia Amy Gu · inferred
Toronto Innovation Acceleration PartnersToronto
Hike VenturesreportedSan Francisco · $1M – $5M
Radical VenturesreportedToronto · $1M – $25M
In the news
- Phenomic AI Launches with $6 Million Seed Funding,Targeting the Tumour Stroma, An Unresolved Puzzle in the Cancerlifesciencesreview.com · 2020
- University of Toronto Early Stage Technology (UTEST) | PHENOMIC AI RAISES $7.97 MILLION CAD TO IDENTIFY PROMISING CANCER DRUGS - University of Toronto Early Stage Technology (UTEST)utest.to · 2020
- Biotech startup Phenomic AI raises $7.97 million CAD to identify promising cancer drugs | BetaKitbetakit.com · 2020
- Phenomic AI Raises $6M in Financing - FinSMEsfinsmes.com · 2020